Boston Scientific INGENIO Family of Pacemakers Receives CE Mark Approval for use in MRI Scans

Boston Scientific INGENIO Family of Pacemakers Receives CE Mark Approval for use in MRI Scans PR Newswire PARIS, July 27, 2012 PARIS, July 27, 2012 /PRNewswire/ -- First European Implants of INGENIO™ MRI Pacemaker with New Image Ready™ Technology Performed This Week Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for ™ ™use of its INGENIO and ADVANTIO pacemakers in patients in need of a magnetic resonance imaging (MRI) scan. Now equipped with new Image Ready™ technology, the first European implants of the INGENIO MRI pacemaker are being performed in the United Kingdom by Dr. John Bayliss, Consultant Cardiologist at Watford General Hospital, London, in Italy by Prof. Massimo Santini, Director of Cardiology Department, San Filippo Neri, Roma, and in Germany by Dr. Joern Schmitt, Oberarzt der Justus-Liebig Universitätsklinik Gießen. Pacemakers are designed to treat bradycardia, a condition in which the heart beats too slowly, depriving the body of sufficient oxygen. Many patients with pacemakers are restricted from undergoing MRI procedures as magnets may interfere with pacemaker functionality, or cause heating of the lead. With Image Ready technology, INGENIO MRI pacemakers, in combination with TMFINELINE II leads, allow patients to undergo MRI procedures as needed. "A significant number of patients with pacemakers may be affected by other conditions, which often require MRI scanning," said Prof. Santini.